Adelene Q. Perkins
Chief Financial Officer, INFINITY PHARMACEUTICALS, INC.
Companies
- BrukerBoard member May 25, 2017 to now1
- INFINITY PHARMACEUTICALS, INC.Board member Jan 7, 2010 to Sep 12, 20232
- INFINITY PHARMACEUTICALS, INC.Chief executive officer Jan 7, 2010 to Jan 12, 20222
- INFINITY PHARMACEUTICALS, INC.President Jan 16, 2015 to Nov 2, 20163
- INFINITY PHARMACEUTICALS, INC.EVP and Chief Business Officer May 7, 2007 to Jan 9, 20124
- INFINITY PHARMACEUTICALS, INC.Chief financial officer Sep 13, 2006 to Jan 29, 20075
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bruker BRKR29,144 shares6$1.6M at $54.86Feb 15, 2026- INFINITY PHARMACEUTICALS, INC.1,191,738 shares7Sep 12, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 15, 2026Granted 4,520 shares of Bruker6
- Feb 15, 2025Granted 3,298 shares of Bruker8
- Jan 5, 2024Granted 2,377 shares of Bruker9
- Sep 12, 2023Sold 410,196 shares at $0.07 of INFINITY PHARMACEUTICALS, INC.7
- Sep 9, 2023Exercised options 768,133 shares of INFINITY PHARMACEUTICALS, INC.7
- Jan 5, 2023Granted 1,970 shares of Bruker10
- Jan 5, 2022Granted 1,841 shares of Bruker11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARBruker, Board member
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Feb 19, 2025
- 9SEC EDGARForm 4 filed Jan 9, 2024
- 10SEC EDGARForm 4 filed Jan 9, 2023
- 11SEC EDGARForm 4 filed Jan 6, 2022